Phase 2 obesity co-administration study with MC4R agonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide Database lock completed Topline data readout ...
A 32-year-old man developed gastroparesis after taking tirzepatide for weight loss, which isn't approved in India. Doctors ...
PsyPost on MSN2d
Ozempic blindness? Serious vision problems reported in patients taking weight loss medicationsA new study published JAMA Ophthalmology has brought attention to a series of vision problems observed in patients taking ...
Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...
Britain is in the grip of a gastric flu outbreak which has spread from hospitals in Scotland to the south coast, health chiefs said today. Levels of the virus, which has already affected 12 ...
When Trova Wine and Market shut its doors last month after nearly five years in business in Dallas, owner Michelle Bonds pointed to an unexpected reason for closure: GLP-1 weight loss drugs like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback